Search results
Results from the WOW.Com Content Network
Tamsulosin is primarily used for benign prostatic hyperplasia (BPH) and to help with the passage of kidney stones. [13] [14] Tamsulosin, however, appears to be effective only for stones over 4 mm and less than 10 mm in size. [8] Tamsulosin is also used as an add-on treatment for acute urinary retention. People may void more successfully after ...
GLP-1 drugs for weight loss and type 2 diabetes include dulaglutide, liraglutide, and semaglutide. GIP/GLP-1s. These are dual-acting, meaning they target two receptors in the body: gastric ...
[15] [16] It may also hide the early symptoms of certain forms of prostate cancer. [14] Finasteride was patented in 1984 and approved for medical use in 1992. [17] It is available as a generic medication. [18] In 2022, it was the 73rd most commonly prescribed medication in the United States, with more than 9 million prescriptions. [19] [20]
Regular physical activity can help accelerate weight loss, improve metabolism and enhance the benefits of weight loss pills. Aim for 150 minutes per week (or about a half-hour five days a week).
Finasteride was the first 5-ARI to be introduced for medical use. [43] It was marketed for the treatment of BPH in 1992 and was subsequently approved for the treatment of pattern hair loss in 1997. [43] Epristeride was the second 5-ARI to be introduced and was marketed for the treatment of BPH in China in 2000. [14]
Post-finasteride syndrome or PFS refers to a range of intimacy, physical, and mental health symptoms associated with the use of finasteride as a treatment for hair loss and benign prostatic ...
This is also the case for Tamsulosin and it may be assumed that the others alpha-1 blockers work in a similar manner, since Tamsulosin is an alpha-1-a blocker and Prazosin is an alpha-1 blocker. [30] The risk for floppy iris syndrome during cataract surgery is elevated when the patient is using an alpha-1 blocker.
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now. GLP-1s ...